Dr. Rima El-Abassi, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $185,370 | 86 | 72.4% |
| Travel and Lodging | $41,643 | 105 | 16.3% |
| Consulting Fee | $18,648 | 7 | 7.3% |
| Food and Beverage | $8,791 | 226 | 3.4% |
| Honoraria | $1,400 | 1 | 0.5% |
| Education | $35.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $223,767 | 250 | $0 (2024) |
| ARGENX US, INC. | $18,351 | 28 | $0 (2024) |
| CSL Behring | $6,642 | 9 | $0 (2024) |
| UCB, Inc. | $4,285 | 14 | $0 (2024) |
| ABBVIE INC. | $693.74 | 43 | $0 (2024) |
| SK Life Science, Inc. | $499.23 | 22 | $0 (2024) |
| EDW Pharma, Inc. | $201.74 | 1 | $0 (2024) |
| Neurelis, Inc. | $196.15 | 8 | $0 (2023) |
| Grifols USA, LLC | $192.41 | 2 | $0 (2023) |
| Sarepta Therapeutics, Inc. | $167.61 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,485 | 68 | Alexion Pharmaceuticals, Inc. ($20,227) |
| 2023 | $67,813 | 98 | Alexion Pharmaceuticals, Inc. ($58,981) |
| 2022 | $86,633 | 129 | Alexion Pharmaceuticals, Inc. ($73,548) |
| 2021 | $14,265 | 20 | Alexion Pharmaceuticals, Inc. ($14,183) |
| 2020 | $12,018 | 18 | Alexion Pharmaceuticals, Inc. ($10,497) |
| 2019 | $46,542 | 85 | Alexion Pharmaceuticals, Inc. ($46,329) |
| 2018 | $50.00 | 3 | GENZYME CORPORATION ($22.14) |
| 2017 | $79.97 | 5 | UCB, Inc. ($52.72) |
All Payment Transactions
426 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Neurology | ||||||
| 12/02/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Neurology | ||||||
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Neurology | ||||||
| 11/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Neurology | ||||||
| 11/11/2024 | EDW Pharma, Inc. | Tiglutik (Drug) | Food and Beverage | In-kind items and services | $201.74 | General |
| Category: Neurology | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.81 | General |
| 10/22/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Neurology | ||||||
| 10/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Neurology | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $39.92 | General |
| Category: Neurology | ||||||
| 10/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Neurology | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ITF Therapeutics LLC | — | Food and Beverage | In-kind items and services | $15.78 | General |
| 09/24/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Neurology | ||||||
| 09/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: Neurology | ||||||
| 09/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Neurology | ||||||
| 08/27/2024 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,940.00 | General |
| 08/27/2024 | Alexion Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $869.13 | General |
| 08/27/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $112.46 | General |
| 08/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Rare Disease | ||||||
| 08/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.64 | General |
| 07/29/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 23 | 38 | $15,789 | $4,698 |
| 2022 | 1 | 16 | 30 | $10,546 | $3,443 |
| 2021 | 1 | 24 | 42 | $13,902 | $5,276 |
| 2020 | 1 | 21 | 27 | $8,937 | $2,593 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 38 | $15,789 | $4,698 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 30 | $10,546 | $3,443 | 32.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 42 | $13,902 | $5,276 | 37.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 27 | $8,937 | $2,593 | 29.0% |
About Dr. Rima El-Abassi, M.D
Dr. Rima El-Abassi, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1417143330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rima El-Abassi, M.D has received a total of $255,887 in payments from pharmaceutical and medical device companies, with $28,485 received in 2024. These payments were reported across 426 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($185,370).
As a Medicare-enrolled provider, El-Abassi has provided services to 84 Medicare beneficiaries, totaling 137 services with total Medicare billing of $16,010. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neuromuscular Medicine
- Location New Orleans, LA
- Active Since 09/25/2007
- Last Updated 04/14/2024
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417143330
Products in Payments
- Soliris (Drug) $53,386
- ULTOMIRIS (Biological) $52,812
- VYVGART (Drug) $10,711
- SOLIRIS (Biological) $8,348
- Hizentra (Biological) $6,642
- Zilbrysq (Drug) $4,056
- VYVGART HYTRULO (Drug) $1,880
- UBRELVY (Drug) $358.39
- Briviact (Drug) $229.42
- QULIPTA (Drug) $227.60
- Tiglutik (Drug) $201.74
- VALTOCO (Drug) $196.15
- Gamunex-C (Biological) $192.41
- BOTOX (Biological) $171.40
- Aimovig (Biological) $145.50
- PANZYGA (Biological) $124.02
- NUEDEXTA (Drug) $102.56
- VYEPTI (Biological) $78.61
- NURTEC ODT (Drug) $69.01
- Fycompa (Drug) $43.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New Orleans
Dr. Patrick Greiffenstein, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $214,722
Veronica Gillispie, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $126,771
Michael Bernard, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $121,414
Nicole Lapinel, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $114,205
Lingling Du, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $94,740
Pavan Chava, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $70,128